Do efforts to decrease door-to-needle time risk increasing stroke mimic treatment rates?
نویسندگان
چکیده
منابع مشابه
Reducing door to needle time for stroke thrombolysis
Better outcomes are obtained with stroke thrombolysis the more rapidly it is given, both in terms of the patient's level of functional ability and also mortality. Current UK performance targets (outside London) aim for a time of 45 minutes or less. Thrombolysis pathways involve multidisciplinary working across departmental boundaries as well as senior level decision making. Our system used tele...
متن کاملImproving Door-to-Needle Times for Acute Ischemic Stroke
Faster treatment with intravenous alteplase (tissue-type plasminogen activator) results in better outcomes. Although the benchmark door-to-needle time (DTN) has been set at 60 minutes, many centers have been able to exceed this benchmark with median times from 20 to 51 minutes. These local efforts have been supported by national and international efforts to reduce DTN time. For example, the Ame...
متن کاملGood is not Good Enough: The Benchmark Stroke Door-to-Needle Time Should be 30 Minutes.
Noreen Kamal, Oscar Benavente, Karl Boyle, Brian Buck, Ken Butcher, Leanne K. Casaubon, Robert Côté, Andrew M Demchuk, Yan Deschaintre, Dar Dowlatshahi, Gordon J Gubitz, Gary Hunter, Tom Jeerakathil, Albert Jin, Eddy Lang, Sylvain Lanthier, Patrice Lindsay, Nancy Newcommon, Jennifer Mandzia, Colleen M. Norris, Wes Oczkowski, Céline Odier, Stephen Phillips, Alexandre Y Poppe, Gustavo Saposnik, D...
متن کاملDelays in Door-to-Needle Times and Their Impact on Treatment Time and Outcomes in Get With The Guidelines-Stroke.
BACKGROUND AND PURPOSE Despite quality improvement programs such as the American Heart Association/American Stroke Association Target Stroke initiative, a substantial portion of acute ischemic stroke patients are still treated with tissue-type plasminogen activator (alteplase) later than 60 minutes from arrival. This study aims to describe the documented reasons for delays and the associations ...
متن کاملImproving Door to Needle time in Patients for Thrombolysis
Ischaemic stroke can result in approximately 2 million brain neurones being damaged for each minute that it is left untreated. Various trials and studies such as the National Institute of Neurologic Disorders (NINDS) trial, the European Cooperative Acute Stroke Study (ECASS), ECASS II, and the Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke (ATLANTIS) study have cl...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Neurology: Clinical Practice
سال: 2015
ISSN: 2163-0402,2163-0933
DOI: 10.1212/cpj.0000000000000122